Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI): Complete Statistical AnalysisIndependent statistical analysis of SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI): primary endpoint results, effect estimate with confidence interval, sample-size…
- Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety Study of GSK Biologicals’ Rotavirus Vaccine (Rotarix®) Administered to Children Aged <1 Year in the United States: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of GSK Biologicals' Rotavirus Vaccine (Rotarix®) Administered to Children Aged
- Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety Study of Inhaled Carbon Monoxide to Treat Pneumonia and Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS): Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Inhaled Carbon Monoxide to Treat Pneumonia and Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777): Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety Study of Kedbumin 25% Versus Normal Saline in the Treatment of Post-Surgical Hypovolemia in Pediatric Patients: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Kedbumin 25% Versus Normal Saline in the Treatment of Post-Surgical Hypovolemia in Pediatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety Study of Levocetirizine Oral Solution for Japanese Pediatrics: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Levocetirizine Oral Solution for Japanese Pediatrics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01563081).
- Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008): Complete Statistical AnalysisIndependent statistical analysis of Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01678807).
- Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety Study of Oral Edaravone Administered in Subjects With ALS: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Oral Edaravone Administered in Subjects With ALS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04165824).
- Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081): Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety Study of RMJH-111b to Treat Essential Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of RMJH-111b to Treat Essential Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02822222).
- Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size…
- Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02039401).
- Safety Study of XP12B in Women With Menorrhagia: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of XP12B in Women With Menorrhagia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00113568).
- Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose: Complete Statistical AnalysisIndependent statistical analysis of Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose: primary endpoint results, effect estimate with confidence interval, sample-size…
- Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital: Complete Statistical AnalysisIndependent statistical analysis of Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy: Complete Statistical AnalysisIndependent statistical analysis of Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying…
- Safety Surveillance of Pneumococcal 13-valent Conjugate Vaccine Among Filipinos: Complete Statistical AnalysisIndependent statistical analysis of Safety Surveillance of Pneumococcal 13-valent Conjugate Vaccine Among Filipinos: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01396434).
- Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers.: Complete Statistical AnalysisIndependent statistical analysis of Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers.: primary endpoint results, effect estimate with confidence interval,…
- Safety, Dose Tolerance, Pharmacokinetics, Pharmacodynamics of CPX-POM in Patients With Newly Diagnosed or Recurrent Bladder Tumors: Complete Statistical AnalysisIndependent statistical analysis of Safety, Dose Tolerance, Pharmacokinetics, Pharmacodynamics of CPX-POM in Patients With Newly Diagnosed or Recurrent Bladder Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety, Efficacy and Pharmacokinetic Study of Dexmedetomidine in Pediatrics Ages ≥28 Weeks to ≤44 Weeks Gestational Age: Complete Statistical AnalysisIndependent statistical analysis of Safety, Efficacy and Pharmacokinetic Study of Dexmedetomidine in Pediatrics Ages ≥28 Weeks to ≤44 Weeks Gestational Age: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea: Complete Statistical AnalysisIndependent statistical analysis of Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder: Complete Statistical AnalysisIndependent statistical analysis of Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease: Complete Statistical AnalysisIndependent statistical analysis of Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety, Efficacy, and Pharmacokinetics of SKY0402 Administered as a Nerve Block in Subjects Undergoing Bunionectomy: Complete Statistical AnalysisIndependent statistical analysis of Safety, Efficacy, and Pharmacokinetics of SKY0402 Administered as a Nerve Block in Subjects Undergoing Bunionectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety, Efficacy, and Side Effects Study of Interventional Cryotherapy in the Pleural Space(“ICE PLS”): Complete Statistical AnalysisIndependent statistical analysis of Safety, Efficacy, and Side Effects Study of Interventional Cryotherapy in the Pleural Space("ICE PLS"): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH: Complete Statistical AnalysisIndependent statistical analysis of Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH: primary endpoint results, effect estimate with confidence interval,…
- Safety, Efficacy, Longitudinal Costs and Patient-Centered Outcomes Using a TAAA Debranching Device: Complete Statistical AnalysisIndependent statistical analysis of Safety, Efficacy, Longitudinal Costs and Patient-Centered Outcomes Using a TAAA Debranching Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in Infants: Complete Statistical AnalysisIndependent statistical analysis of Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety, Immunogenicity and Efficacy of the Blood-stage Plasmodium Vivax Malaria Vaccine Candidate PvDBPII in Matrix M1: Complete Statistical AnalysisIndependent statistical analysis of Safety, Immunogenicity and Efficacy of the Blood-stage Plasmodium Vivax Malaria Vaccine Candidate PvDBPII in Matrix M1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety, Immunogenicity of RTS,S/AS02A, and RTS,S/AS01B Malaria Vaccines in Malaria-experienced Adults.: Complete Statistical AnalysisIndependent statistical analysis of Safety, Immunogenicity of RTS,S/AS02A, and RTS,S/AS01B Malaria Vaccines in Malaria-experienced Adults.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Malaria Transmission Season in Healthy African Adult Women of Childbearing Potential in Mali: Complete Statistical AnalysisIndependent statistical analysis of Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Malaria Transmission Season in Healthy African Adult Women of Childbearing Potential in Mali:…